Screening and delineation of molecular mechanisms of action of HbF inducing agents for the treatment of β-thalassaemia
Current agents used for pharmacological reactivation of foetal haemoglobin (HbF) have limited application due to moderate therapeutic properties, variable patient response and potential cytotoxic effects. Therefore, identification of novel HbF inducing agents is still a major research goal to this d...
Main Author: | Theodorou, Andria Soteri |
---|---|
Other Authors: | Thein, Swee Lay |
Published: |
King's College London (University of London)
2015
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.677113 |
Similar Items
-
Advancing lentiviral gene therapy vectors for β-thalassaemia
by: Stephanou, Coralea
Published: (2015) -
Ameliorating β-thalassaemia by manipulating expression of the α-globin gene
by: Mettananda, Doluweera Sachith Gopeetha
Published: (2015) -
Novel approaches to thalassaemia gene therapy
by: Azevedo Ferreira, Sónia
Published: (2013) -
Genetic basis of HbF and F cell production in human adults
by: Tatu, Thanusak
Published: (2001) -
HbE and HbF levels in HbE/βO-thalassemia are heterogeneous
by: Thanusak Tatu, et al.
Published: (2011-01-01)